RTSL fundamentals
An in-depth look to Rapid Therapeutic Science Laboratories, Inc. operating, investing, and financing activities
RTSL free cash flow for Q4 23 is -8.44 k USD. For 2023, RTSL free cash flow was -31.15 k USD and operating cash flow was -31.14 k USD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM